AWH Capital’s NanoViricides NNVC Stock Holding History

AWH Capital’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,500	Closed	-$48K	–	42
2020 Q3	$48K	Buy	+12,500	New	+$68.5K	0.07%	41

Other funds holding NNVC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

AWH Capital's NNVC Position: Q4 2020 in Review

AWH Capital sold out of NanoViricides (NNVC) in Q4 2020, closing a stake of 12,500 shares — an estimated $48K sold.

AWH Capital first reported a position in NNVC in Q3 2020 and held it in 1 quarter. The position peaked at $48K in Q3 2020. 29 funds tracked by Wall St. Rank hold NNVC as of Q4 2020.

AWH Capital reported no remaining NanoViricides position as of Q4 2020 after selling out during the quarter.
AWH Capital sold 12,500 NanoViricides shares in Q4 2020, an estimated $48K.
AWH Capital first reported a position in NanoViricides in Q3 2020 and held it in 1 quarter.
AWH Capital's NanoViricides position peaked at $48K in Q3 2020.
29 funds tracked by Wall St. Rank held NanoViricides as of Q4 2020.

Based on AWH Capital's 13F filing for Q4 2020, filed 16 Feb 2021.